243
Participants
Start Date
May 31, 2010
Primary Completion Date
August 31, 2012
Study Completion Date
August 31, 2012
pegaptanib sodium
Intravitreal injection of 0.3 mg every 6 weeks
sham injection
sham injection every 6 weeks
Nagoya City University Hospital, Nagoya
Nagoya University Hospital, Nagoya
National Hospital Organization Nagoya Medical Center, Nagoya
Akita University Hospital, Akita
Aomori Prefectural Chuo Hospital, Aomori
Chiba University Hospital, Chiba
Juntendo University Hospital Urayasu, Ophthalmology, Urayasu-shi
Hayashi Eye Hospital, Fukuoka
Kyushu University Hospital, Fukuoka
Murakami Karindo Hospital, Fukuoka
Ohshima Hospital of Ophthalmology, Fukuoka
St. Mary's Hospital, Kurume
Fukushima Medical University Hospital, Fukushima
Gunma University Hospital, Maebashi
Kimura Eye & Internal Medicine Hospital, Kure
Asahikawa Medical College Hospital, Asahikawa
Yoshida Eye Hospital, Hakodate
Hokkaido University Hospital, Sapporo
Hyogo Prefectural Amagasaki Hospital, Amagasaki
Kobe City Medical Center General Hospital, Kobe
Kohnan Hospital, Kobe
Hitachi General Hospital, Hitachi
Mito Kyodo General Hospital, Mito
Kagawa University Hospital, Kida-gun
Kagoshima University Hospital, Kagoshima
Ideta eye hospital, Kumamoto
Kyoto University Hospital, Kyoto
NTT East Tohoku Hospital, Sendai
Shinshu University Hospital, Matsumoto
Nara Medical University Hospital, Kashihara
Niigata University Medical and Dental Hospital, Niigata
Osaka City University Hospital, Osaka
Osaka general medical center, Osaka
Osaka Saiseikai Izou Hospital, Osaka
Kinki University Hospital, Anesthesiology, Osaka-sayama-shi
Saga Prefectural Hospital Koseikan, Saga
Shiga University of Medical Science Hospital, Ōtsu
Seirei Hamamatsu General Hospital, Hamamatsu
Nihon University Surugadai Hospital, Chiyoda-ku
Ochanomizu Inoue Eye Clinic, Chiyoda-ku
National Hospital Organization Tokyo Medical Center, Meguro-ku
Keio University Hospital, Shinjuku-ku
Hirota Eye Clinic, Shūnan
Lead Sponsor
Pfizer
INDUSTRY